NMRA
Asset Logo

NEUMORA THERAPEUTICS, INC.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-13.22%
Annual Growth

1 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.

📈 Performance

Price History*

-15.37%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$13.64

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in NMRA

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

12 weeks

💵 Average investment amount

$5,727

Last time a customer invested in NMRA

272 days
NMRA investor breakdown
💵 Income of investors

More than 200k

100%

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in NMRA also invest in...

BioNano Genomics Inc

BNGO

🙌 Performance (5Yr p.a)

-14.72%

📊 Share price

$0.28 USD
Find Out More

📊 Share price

$7.84 USD

📊 Share price

$7.77 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-19.97%

📊 Share price

$0.01 USD

🙌 Performance (5Yr p.a)

4.75%

📊 Share price

$5.89 USD
Compare
Add to watchlist